Search clinical trials for: placebo to tiotropium olodaterol
Total 1295 results
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Boehringer IngelheimCompleted
-
Erasme University HospitalCompletedPulmonary Disease, Chronic ObstructiveBelgium
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Canada, Netherlands, Germany
-
University of DundeeBoehringer Ingelheim; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Guangzhou Institute of Respiratory DiseaseBoehringer IngelheimRecruitingChronic Obstructive Pulmonary DiseaseChina
-
Boehringer IngelheimCompletedAsthmaAustria, Germany, Poland, Romania, Slovakia, Slovenia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Finland, Germany, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, China, Germany, New Zealand, Taiwan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
Orion Corporation, Orion PharmaCompletedHealthy Volunteer | COPDEstonia
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, India, South Africa, Croatia, Estonia, Poland, Lithuania, Guatemala, Czech Republic, France, Philippines, Korea, Republic of, Taiwan, Canada, Latvia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Spain, Canada, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, China, Germany, Taiwan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Netherlands, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
Theravance BiopharmaViatris Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
NovartisCompletedLung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPDUnited States, Germany, Spain, Argentina, Italy, Turkey, Canada, India, Sweden, Korea, Republic of, Taiwan, Puerto Rico
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
-
Verona Pharma plcCompletedChronic Obstructive Pulmonary Disease Moderate
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Virginia Commonwealth UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure With Normal Ejection FractionUnited States
-
The Archer-Daniels-Midland CompanyMerieux NutriSciences (China)Not yet recruitingGastrointestinal Dysfunction
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Bulgaria, Germany, Guatemala, Hungary, Israel, Latvia, Mexico, Philippines, Portugal, South Africa, Ukraine
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Germany, Latvia, Lithuania, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Germany, Guatemala, Hungary, Latvia, Lithuania, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, Romania, Russian Federation, South Africa, Spain, Sweden, Thailand
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, South Africa, Sweden
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, Sweden
-
Teva Branded Pharmaceutical Products R&D, Inc.WithdrawnChronic Obstructive Pulmonary Disease | COPD